Publication:
Nicorandil Mitigates Glutamate Excitotoxicity in Primary Cultured Neurons

dc.contributor.authorOkkay, Ufuk
dc.contributor.authorHacimuftuoglu, Ahmet
dc.contributor.authorGenç, Sıdıka
dc.contributor.authorYeni, Yeşim
dc.contributor.authorOkkay, Irmak Ferah
dc.contributor.authorBalpınar, Özge
dc.contributor.authorErtugrul, Muhammed Saıt
dc.date.accessioned2025-12-11T01:47:47Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-tempAtatürk Üniversitesi,Atatürk Üniversitesi,Bilecik Şeyh Edebali Üniversitesi,Malatya Turgut Özal Üniversitesi,Atatürk Üniversitesi,Ondokuz Mayıs Üniversitesi,Ondokuz Mayıs Üniversitesien_US
dc.description.abstractExcitotoxicity, caused by the excessive release of glutamate, leads to the activation of the apoptotic process, making it a crucial factor in age-related neurodegenerative diseases. The aim of this study was to investigate the potential of nicorandil to prevent glutamate excitotoxicity and reduce oxidative stress in the brain by analyzing the effects of nicorandil on primary cortex neurons. The study used primary neuron cultures from newborn Sprague-Dawley rats to examine the impact of nicorandil on cell viability, Superoxide Dismutase, Catalase, Glutathione activity, Malondialdehyde levels, total antioxidant capacity, and total antioxidant status of neurons subjected to glutamate-induced excitotoxicity. Nicorandil at varying concentrations was introduced in the culture to assess its protective effects on the neurons. The results showed that nicorandil significantly improved cell viability and total antioxidant capacity levels and reduced total antioxidant status values in a concentration-dependent manner. These findings indicate that nicorandil effectively prevented glutamate excitotoxicity by reducing oxidative stress. The study suggests that nicorandil holds the potential for treating neurodegenerative diseases caused by glutamate excitotoxicity. This study is the first to report the potential of nicorandil to inhibit oxidative stress and prevent glutamate excitotoxicity in primary neurons, providing a basis for further exploration of the clinical application of nicorandil in neurodegenerative diseases.en_US
dc.identifier.doi10.5455/medscience.2023.07.112
dc.identifier.endpage47en_US
dc.identifier.issn2147-0634
dc.identifier.issue1en_US
dc.identifier.startpage43en_US
dc.identifier.trdizinid1244562
dc.identifier.urihttps://doi.org/10.5455/medscience.2023.07.112
dc.identifier.urihttps://search.trdizin.gov.tr/en/yayin/detay/1244562/nicorandil-mitigates-glutamate-excitotoxicity-in-primary-cultured-neurons
dc.identifier.urihttps://hdl.handle.net/20.500.12712/46347
dc.identifier.volume13en_US
dc.language.isoenen_US
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiyolojien_US
dc.subjectTıbbi Araştırmalar Deneyselen_US
dc.titleNicorandil Mitigates Glutamate Excitotoxicity in Primary Cultured Neuronsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files